Literature DB >> 29339403

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium.

Weili Sun1,2,3, Timothy Triche3,4,5, Jemily Malvar2,3, Paul Gaynon2,3, Richard Sposto2,3,6, Xiaojing Yang7, Henrique Bittencourt8, Andrew E Place9,10, Yoav Messinger11, Chris Fraser12, Luciano Dalla-Pozza13, Bodour Salhia3,4, Peter Jones2,5, Alan S Wayne2,3, Lia Gore14,15, Todd M Cooper16, Gangning Liang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29339403      PMCID： PMC5863703          DOI： 10.1182/blood-2017-09-803809

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  19 in total

1.  Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.

Authors:  A Sander; M Zimmermann; M Dworzak; G Fleischhack; C von Neuhoff; D Reinhardt; G J L Kaspers; U Creutzig
Journal:  Leukemia       Date:  2010-06-10       Impact factor: 11.528

2.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

4.  AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  Todd M Cooper; Janet Franklin; Robert B Gerbing; Todd A Alonzo; Craig Hurwitz; Susana C Raimondi; Betsy Hirsch; Franklin O Smith; Prasad Mathew; Robert J Arceci; James Feusner; Robert Iannone; Robert S Lavey; Soheil Meshinchi; Alan Gamis
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

5.  Methylation specific PCR to characterize methylation of the promoter of deoxycytidine kinase.

Authors:  G J Peters; J Hodzic; B Ortega; E Giovannetti; A D Adema; R Broekhuizen; G J Kaspers; I Hubeek
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2010-06       Impact factor: 1.381

6.  Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.

Authors:  Teena Bhatla; Jinhua Wang; Debra J Morrison; Elizabeth A Raetz; Michael J Burke; Patrick Brown; William L Carroll
Journal:  Blood       Date:  2012-04-11       Impact factor: 22.113

7.  Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  K Nguyen; M Devidas; S-C Cheng; M La; E A Raetz; W L Carroll; N J Winick; S P Hunger; P S Gaynon; M L Loh
Journal:  Leukemia       Date:  2008-09-25       Impact factor: 11.528

Review 8.  Strategies for reversing drug resistance.

Authors:  Tito Fojo; Susan Bates
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

9.  Cellular differentiation, cytidine analogs and DNA methylation.

Authors:  P A Jones; S M Taylor
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

10.  A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

Authors:  Robert J Arceci; Bodour Salhia; Lia Gore; Timothy J Triche; Jason E Farrar; Daniel Wai; Christophe Legendre; Gerald C Gooden; Winnie S Liang; John Carpten; David Lee; Frank Alvaro; Margaret E Macy; Carola Arndt; Philip Barnette; Todd Cooper; Laura Martin; Aru Narendran; Jessica Pollard; Soheil Meshinchi; Jessica Boklan
Journal:  Clin Epigenetics       Date:  2017-10-05       Impact factor: 6.551
View more
  16 in total

Review 1.  Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies.

Authors:  Sara Zarnegar-Lumley; Kenneth J Caldwell; Jeffrey E Rubnitz
Journal:  Leukemia       Date:  2022-06-06       Impact factor: 12.883

Review 2.  High-Risk Acute Myeloid Leukemia: A Pediatric Prospective.

Authors:  Fabiana Cacace; Rossella Iula; Danilo De Novellis; Valeria Caprioli; Maria Rosaria D'Amico; Giuseppina De Simone; Rosanna Cuccurullo; William G Wierda; Kris Michael Mahadeo; Giuseppe Menna; Francesco Paolo Tambaro
Journal:  Biomedicines       Date:  2022-06-14

3.  Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

Authors:  Lauren Pommert; Eric S Schafer; Jemily Malvar; Nathan Gossai; Ellynore Florendo; Kirthi Pulakanti; Katelyn Heimbruch; Cary Stelloh; Yueh-Yun Chi; Richard Sposto; Sridhar Rao; Van Thu Huynh; Patrick Brown; Bill H Chang; Susan I Colace; Michelle L Hermiston; Kenneth Heym; Raymond J Hutchinson; Joel A Kaplan; Rajen Mody; Tracey A O'Brien; Andrew E Place; Peter H Shaw; David S Ziegler; Alan Wayne; Deepa Bhojwani; Michael J Burke
Journal:  Am J Hematol       Date:  2022-03-08       Impact factor: 13.265

4.  KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.

Authors:  Fangxue Yan; Jinyang Li; Jelena Milosevic; Ricardo Petroni; Suying Liu; Zhennan Shi; Salina Yuan; Janice M Reynaga; Yuwei Qi; Joshua Rico; Sixiang Yu; Yiman Liu; Susumu Rokudai; Neil Palmisiano; Sara E Meyer; Pamela J Sung; Liling Wan; Fei Lan; Benjamin A Garcia; Ben Z Stanger; David B Sykes; M Andrés Blanco
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

5.  Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine.

Authors:  Hitoshi Ohtani; Andreas D Ørskov; Alexandra S Helbo; Linn Gillberg; Minmin Liu; Wanding Zhou; Johanna Ungerstedt; Eva Hellström-Lindberg; Weili Sun; Gangning Liang; Peter A Jones; Kirsten Grønbæk
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

6.  A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.

Authors:  Michael A Koldobskiy; Jordi Abante; Garrett Jenkinson; Elisabet Pujadas; Ashley Tetens; Feifei Zhao; Rakel Tryggvadottir; Adrian Idrizi; Andreas Reinisch; Ravindra Majeti; John Goutsias; Andrew P Feinberg
Journal:  Epigenetics       Date:  2020-02-29       Impact factor: 4.528

Review 7.  Treatments for children and adolescents with AML.

Authors:  Hyery Kim
Journal:  Blood Res       Date:  2020-07-31

8.  Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.

Authors:  Wen-Hsin Liu; Paulina Mrozek-Gorska; Anna-Katharina Wirth; Tobias Herold; Larissa Schwarzkopf; Dagmar Pich; Kerstin Völse; M Camila Melo-Narváez; Michela Carlet; Wolfgang Hammerschmidt; Irmela Jeremias
Journal:  Biomark Res       Date:  2020-09-16

9.  Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.

Authors:  Jamie L Grit; Benjamin K Johnson; Patrick S Dischinger; Curt J Essenburg; Marie Adams; Stacy Campbell; Kai Pollard; Christine A Pratilas; Tim J Triche; Carrie R Graveel; Matthew R Steensma
Journal:  Epigenetics Chromatin       Date:  2021-01-13       Impact factor: 4.954

10.  Changes in IDH2, TET2 and KDM2B Gene Expression After Treatment With Classic Chemotherapeutic Agents and Decitabine in Myelogenous Leukemia Cell Lines.

Authors:  Jayse Alves; Georgia Muccillo Dexheimer; Laura Reckzigel; Marcia Goettert; Vanderlei Biolchi; Ana Lucia Abujamra
Journal:  J Hematol       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.